Chemically Modifying IL-2 to Optimize Delivery to Tregs for Sustained Responses

Time: 4:00 pm
day: Day One | Track B | Afternoon


  • Overview of PEGylated IL2v to enhance activation of Tregs with high specificity and maintain stability
  • Highlighting preclinical data to predict clinical efficacy of PEGylated IL2v
  • Overcoming the challenges to translate from preclinical models to humans